A Study of the Prevalence and Risk Factors for Hepatitis C Virus Infection Among Injection Drug Users in Northern and Eastern France

Author(s): Lucidarme D

Publishing year: 2003

Pages: 46 p.

In relation to

Our latest news

news

SIBCA 2026: The UrBaCS network presents its solutions for cities and...

news

Physical Activity and Combating a Sedentary Lifestyle: How Does Santé...

news

Etienne Pot Appointed Interim Director General of Santé publique France